Literature DB >> 17493699

A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.

Konstantin Lavrenkov1, Judith A Christian, Mike Partridge, Elena Niotsikou, Gary Cook, Michelle Parker, James L Bedford, Michael Brada.   

Abstract

BACKGROUND AND
PURPOSE: The study aimed to examine specific avoidance of functional lung (FL) defined by a single photon emission computerized tomography (SPECT) lung perfusion scan, using intensity modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3-DCRT) in patients with non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: Patients with NSCLC underwent planning computerized tomography (CT) and lung perfusion SPECT scan in the treatment position using fiducial markers to allow co-registration in the treatment planning system. Radiotherapy (RT) volumes were delineated on the CT scan. FL was defined using co-registered SPECT images. Two inverse coplanar RT plans were generated for each patient: 4-field 3-DCRT and 5-field step-and-shoot IMRT. 3-DCRT plans were created using automated AutoPlan optimisation software, and IMRT plans were generated employing Pinnacle(3) treatment planning system (Philips Radiation Oncology Systems). All plans were prescribed to 64 Gy in 32 fractions using data for the 6 MV beam from an Elekta linear accelerator. The objectives for both plans were to minimize the volume of FL irradiated to 20 Gy (fV(20)) and dose variation within the planning target volume (PTV). A spinal cord dose was constrained to 46 Gy. Volume of PTV receiving 90% of the prescribed dose (PTV(90)), fV(20), and functional mean lung dose (fMLD) were recorded. The PTV(90)/fV(20) ratio was used to account for variations in both measures, where a higher value represented a better plan.
RESULTS: Thirty-four RT plans of 17 patients with stage I-IIIB NSCLC suitable for radical RT were analysed. In 6 patients with stage I-II disease there was no improvement in PTV(90), fV(20), PTV/fV(20) ratio and fMLD using IMRT compared to 3-DCRT. In 11 patients with stage IIIA-B disease, the PTV was equally well covered with IMRT and 3-DCRT plans, with IMRT producing better PTV(90)/fV(20) ratio (mean ratio - 7.2 vs. 5.3, respectively, p=0.001) and reduced fMLD figures compared to 3-DCRT (mean value - 11.5 vs. 14.3 Gy, p=0.001). This was due to reduction in fV(20) while maintaining PTV coverage.
CONCLUSION: The use of IMRT compared to 3-DCRT improves the avoidance of FL defined by perfusion SPECT scan in selected patients with locally advanced NSCLC. If the dose to FL is shown to be the primary determinant of lung toxicity, IMRT would allow for effective dose escalation by specific avoidance of FL.

Entities:  

Mesh:

Year:  2007        PMID: 17493699     DOI: 10.1016/j.radonc.2007.04.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  30 in total

1.  Functional-guided radiotherapy using knowledge-based planning.

Authors:  Austin M Faught; Lindsey Olsen; Leah Schubert; Chad Rusthoven; Edward Castillo; Richard Castillo; Jingjing Zhang; Thomas Guerrero; Moyed Miften; Yevgeniy Vinogradskiy
Journal:  Radiother Oncol       Date:  2018-04-05       Impact factor: 6.280

Review 2.  A review of intensity-modulated radiation therapy.

Authors:  Laurie E Gaspar; Meisong Ding
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

3.  Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy.

Authors:  Dongqing Wang; Baosheng Li; Zhongtang Wang; Jian Zhu; Hongfu Sun; Jian Zhang; Yong Yin
Journal:  Exp Ther Med       Date:  2011-06-29       Impact factor: 2.447

4.  Image-based lung functional radiotherapy planning for non-small cell lung cancer.

Authors:  Faegheh S Mounessi; Jörg Eckardt; Arne Holstein; Santiago Ewig; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2019-10-02       Impact factor: 3.621

5.  Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.

Authors:  Austin M Faught; Yuya Miyasaka; Noriyuki Kadoya; Richard Castillo; Edward Castillo; Yevgeniy Vinogradskiy; Tokihiro Yamamoto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-26       Impact factor: 7.038

6.  Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.

Authors:  Austin M Faught; Tokihiro Yamamoto; Richard Castillo; Edward Castillo; Jingjing Zhang; Moyed Miften; Yevgeniy Vinogradskiy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-08       Impact factor: 7.038

7.  Reproducibility of four-dimensional computed tomography-based lung ventilation imaging.

Authors:  Tokihiro Yamamoto; Sven Kabus; Jens von Berg; Cristian Lorenz; Melody P Chung; Julian C Hong; Billy W Loo; Paul J Keall
Journal:  Acad Radiol       Date:  2012-09-10       Impact factor: 3.173

Review 8.  Functional and molecular image guidance in radiotherapy treatment planning optimization.

Authors:  Shiva K Das; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

9.  Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.

Authors:  Shuanghu Tiger Yuan; Kirk A Frey; Milton D Gross; James A Hayman; Doug Arenberg; Xu-Wei Cai; Nithya Ramnath; Khaled Hassan; Jean Moran; Avraham Eisbruch; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-22       Impact factor: 7.038

10.  Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning.

Authors:  Shuanghu Tiger Yuan; Kirk A Frey; Milton D Gross; James A Hayman; Doug Arenberg; Jeffrey L Curtis; Xu-Wei Cai; Nithya Ramnath; Gregory P Kalemkerian; Randall K Ten Haken; Avraham Eisbruch; Feng-Ming Spring Kong
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.